For the 2026 Urological Infections Guidelines new and relevant evidence was identified, collated and appraised through a structured assessment of the literature for sections 3.17 and 3.18.2.h. This resulted in the inclusion of 36 additional studies across the Guidelines. Key changes include:
- Update of the recommendations in Section 3.4.3.d: Summary of evidence and recommendations for the diagnostic evaluation of cystitis.
- Update of the recommendations in Section 3.4.4.d: Summary of evidence and recommendations for antimicrobial therapy for cystitis.
- Addition for a new chapter on the diagnosis and treatment of fungal urinary tract infections: 3.17 Fungal urinary tract infection.
- Update of the evidence and recommendations on periprocedural antibiotic prophylaxis for prostate biopsy in Section 3.18.3: Summary of evidence and recommendations for peri-procedural antibiotic prophylaxis.
- Review and update of antibiotic dosages where appropriate.